RY 171.15 -0.2274% SHOP 181.93 -0.8286% TD 84.84 -0.3407% ENB 60.05 -0.973% BN 86.375 -0.6956% TRI 246.03 -0.1299% CNQ 43.25 0.348% CP 111.71 -0.7199% CNR 145.96 0.1372% BMO 143.21 -0.3964% BNS 71.965 -0.6283% CSU 4916.5 -0.6746% CM 87.86 -0.5321% MFC 42.34 -0.5403% ATD 71.43 -0.8054% NGT 67.62 0.3413% TRP 65.14 -0.9579% SU 56.71 0.3894% WCN 266.4 0.0714% L 178.845 -0.1312%

NervGen Pharma Corp

Healthcare CA NGEN

3.01CAD
0.04(1.35%)

Last update at 2025-02-19T19:38:00Z

Day Range

2.923.01
LowHigh

52 Week Range

1.583.98
LowHigh

Fundamentals

  • Previous Close 2.97
  • Market Cap184.21M
  • Volume13576
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-19.24419M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.38

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -20.72228M -12.72658M -11.18614M -9.76561M -1.35848M
Minority interest - - - - -
Net income -20.72228M -12.72658M -11.18614M -9.76561M -1.35848M
Selling general administrative 6.34M 4.50M 5.03M 3.38M 0.58M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.12M 0.04M 0.04M 0.04M 0.02M
Ebit -23.02503M -12.81122M -11.19588M -9.86443M -1.35848M
Ebitda -20.09257M -11.33470M -11.15624M -9.82621M -1.33872M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -23.02503M -11.37733M -11.19588M -9.86443M -1.35848M
Other operating expenses - - - - -
Interest expense 0.51M 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income 0.20M 0.03M 0.02M 0.10M -
Net interest income -0.31320M -1.40448M 0.02M 0.10M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 23.03M 11.38M 11.20M 9.86M 1.36M
Cost of revenue - - - - -
Total other income expense net 2.62M 0.06M -0.00911M - -
Discontinued operations - - - - -
Net income from continuing ops -20.72228M -12.72658M -11.18614M -9.76561M -1.35848M
Net income applicable to common shares -20.72228M -12.72658M -11.18614M -9.76561M -1.35848M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 13.24M 23.88M 17.90M 6.68M 6.77M
Intangible assets 0.52M 0.43M 0.47M 0.47M 0.51M
Earning assets - - - - -
Other current assets - 0.59M 0.36M 0.49M 1.98M
Total liab 15.25M 10.41M 1.08M 0.76M 0.92M
Total stockholder equity -2.00910M 13.46M 16.82M 5.92M 5.84M
Deferred long term liab